NCT01086761 arm group 5cd79bbd540405150c326cc63e20d089 [clinicaltrials_resource:NCT01086761/arm-group/5cd79bbd540405150c326cc63e20d089]
arm group [clinicaltrials_vocabulary:arm-group]
NCT01086761 arm group 5cd79bbd540405150c326cc63e20d089 [clinicaltrials_resource:NCT01086761/arm-group/5cd79bbd540405150c326cc63e20d089]
Bio2RDF identifier
NCT01086761/arm-group/5cd79bbd540405150c326cc63e20d089
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... d79bbd540405150c326cc63e20d089
description [clinicaltrials_vocabulary:description]
Single 0.4 mg intravitreal injection of MP0112 in the study eye.
identifier
clinicaltrials_resource:NCT01086761/arm-group/5cd79bbd540405150c326cc63e20d089
title
NCT01086761 arm group 5cd79bbd540405150c326cc63e20d089
@en
type
label
NCT01086761 arm group 5cd79bbd ...... 79bbd540405150c326cc63e20d089]
@en